中国·新蒲京娱乐场(8555cc·官网认证)-Latest Official Website

English Chinese
News
Announcement of Gloden i Prize: DHCtech won the 2023 China Innovative Digital Medical Leading Enterprise Award
2023-06-27 Share:

On June 26

On June 26th, 2023, the White Paper on Digital Economy 2023 of the 5th Innovation and Development Forum, sponsored by Internet Weekly of China Academy of Sciences, Information Research Center of China Academy of Social Sciences, eNet Research Institute and Deben Consulting (think-tank), was held in Beijing, and the list of Golden I Awards was announced at the same time. With powerful independent research and development technical strength and rich practical achievements in the medical field, DHCtech won the 2023 China Innovative Digital Medical Leading Enterprise Award.


 90.jpg

 

REASON FOR THE AWARD

 

DHCtech insists on independent innovation, breaks through the barriers between clinical texts, images, genomics and other multimodal data, and innovatively builds a hospital-wide clinical big data platform and integrated application of multimodal diagnosis and treatment research for Southern Hospital with full-chain and one-stop intelligent data processing capabilities, comprehensively improving the efficiency and level of clinical and scientific research, and was selected as the "Pilot Demonstration Project of Big Data Industry Development" by the Ministry of Industry and Information Technology; Jointly build a new cohort study follow-up system "China Heart Valve Disease Clinical Data Research Data Platform" with anzhen hospital to fill the blank of lack of follow-up data for heart valve surgery in China; Establish a multi-modal big data platform for Ganzhou People's Hospital (Southern Hospital Ganzhou Hospital), and innovatively help the construction of high-level national regional medical centers through the integrated data center of lakes and warehouses. DHCtech applies theory to practice and integrates digital and medical care. It is an innovative digital medical leading enterprise with technical strength, innovation power and development potential in China.

-From the Organizing Committee of the Golden i Prize

 

The world is undergoing a new wave of technology and industrial revolution, data resources have become national strategic resources, and big data and artificial intelligence technologies have also penetrated into all walks of life. In the medical and health industry, the application of digital medical treatment has accelerated the pace of smart hospital construction and the high-quality development process of public hospitals, and injected new kinetic energy into the development of the medical and health industry.

 

As a leading enterprise in medical big data and artificial intelligence in China, DHCtech has always highlighted the deep integration of medical big data and artificial intelligence. On the one hand, DHCtech insists on building a data standard system according to international standards, on the other hand, DHCtech focuses on localized R&D innovation of independent intellectual property rights, and develops a closed loop of fusion-governance-analysis that integrates multi-modal and all-type data such as clinical data, imaging data and genomics data, and goes deep into the whole process of screening, diagnosis, governance, management and research in clinic, continuously promoting the overall improvement of clinical value and scientific research value of medical institutions. Since its establishment, DHCtech has carried out more than 40 national scientific research projects and major national projects, becoming the backbone of supporting national technological innovation.

 

With years of first-mover advantage, technical strength and accumulated experience in the field of medical big data and artificial intelligence, DHCtech's products and solutions have been applied in many well-known hospitals and recognized by the industry and hospitals. In the future, DHCtech will continue to focus on four business areas: medical big data, intelligent imaging platform, precision medicine and digitalization of pharmaceutical companies, adhere to independent innovation, break down data barriers, help hospitals to integrate clinical data with genomics data and image data, realize closed-loop integration of multi-group and multi-modal big data, improve the level of diagnosis, treatment and scientific research, promote the high-quality development of hospitals, and promote the digital transformation and upgrading of medical and health industries.


TOP